Validation of Age-adjusted Shock indices for Predicting In-hospital outcomes in percutaneously REvascularized
Bryan Jacob Koithara1, Ravi Kalra2, Shashikala Sangle1
1Department of General Medicine, Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital, Pune-Satara Road, Dhankawadi, Pune, Maharashtra, 411043, India.
Insights
The Age-Shock Index (Age-SI) and Age-Modified Shock Index (Age-MSI) effectively predict major adverse cardiovascular events and mortality in ST-elevation myocardial infarction patients post-PCI, offering bedside risk stratification alternatives.
Area of Science:
- Cardiology
- Clinical Research
- Medical Informatics
Background:
- ST-elevation myocardial infarction (STEMI) requires prompt revascularization.
- Accurate prediction of in-hospital outcomes is crucial for patient management.
- Existing risk scores like GRACE may have limitations in certain populations.
Purpose of the Study:
- To prospectively validate the Age-Shock Index (Age-SI) and Age-Modified Shock Index (Age-MSI) in Indian STEMI patients.
- To compare the predictive performance of Age-SI and Age-MSI against the GRACE score for in-hospital MACE and mortality.
- To assess the utility of Age-SI and Age-MSI for bedside risk stratification post-percutaneous coronary intervention (PCI).
Main Methods:
- Prospective evaluation of 236 STEMI patients undergoing PCI.
- Calculation and analysis of Age-SI, Age-MSI, and GRACE scores.
- Determination of optimal cut-off values for predicting major adverse cardiovascular events (MACE) and all-cause mortality.
Main Results:
- Age-SI and Age-MSI demonstrated significant predictive capabilities for both MACE and all-cause mortality.
- Optimal Age-SI cut-offs showed sensitivities/specificities of 76.7%/67% for MACE and 82.4%/83% for mortality.
- Optimal Age-MSI cut-offs showed sensitivities/specificities of 85%/56.2% for MACE and 77%/89% for mortality.
- GRACE score (≥127.5) showed sensitivities/specificities of 60%/81.9% for MACE and 94%/76.7% for mortality.
Conclusions:
- Age-SI and Age-MSI are valuable, simple tools for bedside risk stratification in Indian STEMI patients post-PCI.
- These indices offer a practical alternative to traditional risk scores for predicting in-hospital adverse events.
- Further validation in diverse populations may enhance their clinical applicability.
Abstract:
The ASPIRE-STEMI study prospectively evaluated 236 patients with ST-elevation myocardial infarction undergoing percutaneous revascularization to validate Age-Shock Index (Age-SI) and Age-Modified Shock Index (Age-MSI) as alternatives to the GRACE score for predicting in-hospital major adverse cardiovascular events (MACE) and all-cause mortality. For MACE (n = 60), optimal cut-offs yielded sensitivities/specificities of 76.7 %/67 % (Age-SI ≥ 36.95), 85 %/56.2 % (Age-MSI ≥45.64), and 60 %/81.9 % (GRACE ≥127.5). For all-cause mortality (n = 17), optimal cut-offs yielded sensitivity/specificity of 82.4 %/83 % (Age-SI ≥46.83), 77 %/89 % (Age-MSI ≥67.35), and 94 %/76.7 % (GRACE ≥127.5). While each index independently predicted in-hospital outcomes, Age-SI and Age-MSI offer simple, bedside risk stratification in Indian STEMI patients post-PCI.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
